Med-Chemist: Prana's PBT2 receives FDA Orphan Drug designation for treatment of Huntington disease

Med-Chemist : "Quintessential Medicinal Chemistry"

Saturday, September 6, 2014

Prana's PBT2 receives FDA Orphan Drug designation for treatment of Huntington disease

Prana's PBT2 receives FDA Orphan Drug designation for treatment of Huntington disease

https://www.med-chemist.com at 2:19 PM

View web version

Contributors

Dr. Umesh..
https://www.med-chemist.com

Powered by Blogger.